Chief Financial Officer · agilon health, inc. · Common Stock
Side
A
Value
—
Shares
600.0K
Price
—
Executed
Jan 10, 2026
Disclosed
Jan 13, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jan 10 executedJan 13, 2026 disclosed
AGL · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 55.8% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · AGL
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Schwaneke Jeffrey A. filed this Form 4 reporting a grant or award of AGL on Jan 10, 2026. It became public on Jan 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Schwaneke Jeffrey A.cik:0001446919
Issuer
agilon health, inc.cik:0001831097
Revision history · 0
No field has changed since this record was first ingested.